Illusory misidentifications and cortical hypometabolism in Parkinson's disease

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 837-843

  Ishioka, Toshiyuki ^a   Hirayama, Kazumi ^a   Hosokai, Yoshiyuki ^a   Takeda, Atsushi ^a   Suzuki, Kyoko ^a   Nishio, Yoshiyuki ^a   Sawada, Yoichi ^a   Takahashi, Shoki ^a   Fukuda, Hiroshi ^b   Itoyama, Yasuto ^a   Mori, Etsuro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Illusory misidentification; Overlapping figure identification test; Parkinson's disease; Positron emission tomography; Visual cortices

Indexed keywords

ANTIPARKINSON AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICAL HYPOMETABOLISM; DISEASE MARKER; EDUCATIONAL STATUS; FEMALE; GLUCOSE METABOLISM; HUMAN; ILLUSORY MISIDENTIFICATION; IMAGE RECONSTRUCTION; INFERIOR TEMPORAL GYRUS; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STIMULUS RESPONSE; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL ACUITY; VISUAL CORTEX; VISUAL ILLUSION; VISUAL IMPAIRMENT; VISUAL MEMORY; VISUAL STIMULATION; WECHSLER MEMORY SCALE;

AGED; ANALYSIS OF VARIANCE; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FLUORODEOXYGLUCOSE F18; FUNCTIONAL LATERALITY; HUMANS; ILLUSIONS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECOGNITION (PSYCHOLOGY); VISUAL ACUITY;

EID: 79955083640     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23576     Document Type: Article

References (47)

1. Waterfall ML, Crowe SF. Meta-analytic comparison of the components of visual cognition in Parkinson's disease. J Clin Exp Neuropsychol 1995; 17: 759-772.
2. Bodis-Wollner I. Neuropsychological and perceptual defects in Parkinson's disease. Parkinsonism Relat Disord 2003; 9: S83-S89.
3. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003; 74: 419-422.
4. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003; 20: 1309-1319.
5. Hosokai Y, Nishio Y, Hirayama K, et al. Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord 2009; 24: 854-862.
6. Mentis MJ, McIntosh AR, Perrine K, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 2002; 159: 746-754.
7. Mishkin M, Ungerleider LG, Macko KA. Object vision and spatial vision: two cortical pathways. Trends Neurosci 1983; 6: 414-417.
8. Ungerleider LG, Haxby JV. 'What' and 'where' in the human brain. Curr Opin Neurobiol 1994; 4: 157-165.
9. Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bargallo N, Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009; 24: 1193-1199.
10. Poppelreuter W. Die Psychischen Schaedungen durch Kopfschuss in Kriege Leipzig Leopold Voss, 1917.
11. Bisiach E, Capitani E, Nichelli P, Spinnler H. Recognition of overlapping patterns and focal hemisphere damage. Neuropsychologia 1976; 14: 375-379.
12. Poeck K, Kerschensteiner M, Hartje W, Orgass B. Impairment in visual recognition of geometric figures in patients with circumscribed retrorolandic brain lesions. Neuropsychologia 1973; 11: 311-317.
13. Larsson J, Amunts K, Gulyas B, Malikovic A, Zilles K, Roland PE. Perceptual segregation of overlapping shapes activates posterior extrastriate visual cortex in man. Exp Brain Res 2002; 143: 1-10.
14. Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41: 365-369.
15. Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004; 63: 2091-2096.
16. Mori E, Shimomura T, Fujimori M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57: 489-493.
17. Pillon B, Dubois B, Bonnet AM, et al. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989; 39: 762-768.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
19. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
20. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
21. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987: 153-163.
22. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
23. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
24. Snodgrass JG, Vanderwart M. A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. J Exp Psychol Hum Learn 1980; 6: 174-215.
25. Mosconi L, Tsui WH, De Santi S, et al. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005; 64: 1860-1867.
26. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995; 346: 1383-1387.
27. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004; 62: 201-207.
28. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987; 110: 1675-1698.
29. Buttner T, Kuhn W, Muller T, Patzold T, Heidbrink K, Przuntek H. Distorted color discrimination in 'de novo' parkinsonian patients. Neurology 1995; 45: 386-387.
30. Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005; 65: 1907-1913.
31. Gerlach C, Law I, Gade A, Paulson OB. Perceptual differentiation and category effects in normal object recognition: a PET study. Brain 1999; 122: 2159-2170.
32. Takahashi N, Kawamura M, Iwata T. Hemi-facial metamorphopsia due to right temporo-occipital lesion (in Japanese). Neurol Med 1996; 45: 252-254.
33. Corballis MC, Corballis PM. Interhemispheric visual matching in the split brain. Neuropsychologia 2001; 39: 1395-1400.
34. Ramachandran VS. Phantoms in the brain. New York: William Morrow and Company, 1998.
35. Arrington CM, Carr TH, Mayer AR, Rao SM. Neural mechanisms of visual attention: object-based selection of a region in space. J Cogn Neurosci 2000; 12: 106-117.
36. Coslett HB, Saffran E. Simultanagnosia. To see but not two see. Brain 1991; 114: 1523-1545.
37. Rizzo M, Hurtig R. Looking but not seeing: attention, perception, and eye movements in simultanagnosia. Neurology 1987; 37: 1642-1648.
38. Luria AR. Disorders of "simultaneous perception" in a case of bilateral occipito-parietal brain injury. Brain 1959; 82: 437-449.
39. Corbetta M, Miezin FM, Shulman GL, Petersen SE. A PET study of visuospatial attention. J Neurosci 1993; 13: 1202-1226.
40. Matsui H, Nishinaka K, Oda M, et al. Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations. Mov Disord 2006; 21: 2140-2144.
41. Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch Neurol 2007; 64: 984-988.
42. Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005; 65: 1708-1715.
43. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: 391-403.
44. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 2005; 4: 605-610.
45. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003; 16: 193-210.
46. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 2008; 70: 1470-1477.
47. Abe N, Fujii T, Hirayama K, et al. Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain 2009; 132: 1386-1395.